CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: Importantly, expression of TCA-related genes, including genes marked with an asterisk (transferred or activated by the BMM) further increased in CD34 + CML cells resistant to either imatinib or 2nd/3rd generation TKIs (group C, pan-TKI resistance).